April 15, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: |
Mitchell Austin |
Re: |
Ekso Bionics Holdings, Inc. Registration Statement on Form S-3 File No. 333-286463 Filed on April 10, 2025 |
Acceleration Request
Requested Date: April 17, 2025
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ekso Bionics Holdings, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-286463) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
|
Sincerely, |
|
EKSO BIONICS HOLDINGS, INC. | ||
|
|
|
|
|
|
|
By: |
/s/ Scott G. Davis |
|
|
Scott G. Davis |
|
|
Chief Executive Officer |
cc: |
Mark B. Baudler, Wilson Sonsini Goodrich & Rosati Austin D. March, Wilson Sonsini Goodrich & Rosati |